Clinical Trial Update: Validation Digital Bio-markers During Sulforaphane Treatment. [NA]

View source ↗

Summary

The document describes an ongoing Rutgers clinical trial evaluating digital biomarkers during sulforaphane treatment for autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Autism, Autism Spectrum Disorder | NA | Status: ENROLLING_BY_INVITATION